Low serum interleukin‐38 levels in patients with Graves’ disease and Hashimoto’s thyroiditis-Reference-Cited by-同舟云学术

Low serum interleukin‐38 levels in patients with Graves’ disease and Hashimoto’s thyroiditis

Published:2021-11-19 Issue:1 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Xu Jialu¹²,Huang Guoqing²³,Weng Linjie²,Gong Luping²,Mao Yushan³,Li Yan²³,Li Mingcai²^ORCID

Affiliation:

1. Department of Clinical Laboratory The Affiliated Lihuili Hospital, Ningbo University Ningbo China

2. Department of Immunology, Zhejiang Key Laboratory of Pathophysiology Ningbo University School of Medicine Ningbo China

3. Department of Endocrinology, The Affiliated Hospital of Medical School Ningbo University Ningbo China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24101

Reference30 articles.

1. Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy

2. Evidence for a Major Role of Heredity in Graves' Disease: A Population-Based Study of Two Danish Twin Cohorts

3. Graves’ Disease

4. Graves' Disease

5. The level of IL-35 in the circulation of patients with Graves’ disease

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of IL-8, IL-38, Vitamin D, TPO Ab, and CRP Levels in Iraqi Hashimoto Thyroiditis Patients;Medical Journal of Babylon;2024-04

2. Th1 or Th2 cytokines are correlated with Tregs and T cell subsets and pregnancy outcomes in patients with autoimmune thyroid disease during early, middle, late pregnancy, and postpartum period;Human Immunology;2023-10

3. Interleukin-38 and insulin resistance;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-09-11

4. IL‐38 attenuates myocardial ischemia–reperfusion injury by inhibiting macrophage inflammation;Immunity, Inflammation and Disease;2023-06

5. Assessment of the levels of interleukin-17 and interleukin-38 in thyroid-associated ophthalmopathy patients;International Ophthalmology;2023-03-09